1. Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases
   Nina Zila et al, 2018, Clin Proteom CrossRef
2. E2 ubiquitin-conjugating enzymes in cancer: Implications for immunotherapeutic interventions.
   Seyed Mohammad Hosseini et al, 2019, Clin Chim Acta CrossRef
3. Integrated bioinformatic analysis identifies UBE2Q1 as a potential prognostic marker for high grade serous ovarian cancer
   Rachel Topno et al, 2021, BMC Cancer CrossRef
4. Dysregulation of the Ubiquitin Proteasome System in Human Malignancies: A Window for Therapeutic Intervention.
   Chee Wai Fhu et al, 2021, Cancers (Basel) CrossRef
5. Methylation as a critical epigenetic process during tumor progressions among Iranian population: an overview
   Iman Akhlaghipour et al, 2021, Genes and Environ CrossRef
6. Ubiquitin‑conjugating enzymes as potential biomarkers and therapeutic targets for digestive system cancers (Review)
   Xiangxiang Lei et al, 2023, Oncol Rep CrossRef
7. The crosstalk between ubiquitin-conjugating enzyme E2Q1 and p53 in colorectal cancer: An in vitro analysis
   Maryam Rasouli et al, 2023, Med Oncol CrossRef